Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18693)

• Formulation Name: Raltegravir 400 mg tablet
• Company: State of Florida DOH Central Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Raltegravir	(DMYURI6)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Calcium hydrogenphosphate	(E00294)	24441	Diluent
Eisenoxyd	(E00585)	56841934	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 407	(E00646)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent